These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 17560249

  • 1. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
    Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG, Rees R, Wong SL, Cimmino VM, Chang AE.
    Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
    [Abstract] [Full Text] [Related]

  • 2. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
    de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ.
    Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
    [Abstract] [Full Text] [Related]

  • 3. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
    Nathansohn N, Schachter J, Gutman H.
    Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238
    [Abstract] [Full Text] [Related]

  • 4. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [Abstract] [Full Text] [Related]

  • 5. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
    Sabel MS, Griffith K, Sondak VK, Lowe L, Schwartz JL, Cimmino VM, Chang AE, Rees RS, Bradford CR, Johnson TM.
    J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
    [Abstract] [Full Text] [Related]

  • 6. Management of the lymph nodes in penile cancer.
    Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H.
    Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
    Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, Gershenwald JE, Sussman JJ, Dirk Noyes R, Goydos JS, Beitsch PD, Ariyan S, Stromberg AJ, Hagendoorn LJ, McMasters KM.
    Ann Surg Oncol; 2010 Mar; 17(3):709-17. PubMed ID: 19967459
    [Abstract] [Full Text] [Related]

  • 8. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.
    Allan CP, Hayes AJ, Thomas JM.
    ANZ J Surg; 2008 Nov; 78(11):982-6. PubMed ID: 18959697
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
    Rutkowski P, Nowecki ZI, Zurawski Z, Dziewirski W, Nasierowska-Guttmejer A, Switaj T, Ruka W.
    Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
    [Abstract] [Full Text] [Related]

  • 11. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
    Morris KT, Busam KJ, Bero S, Patel A, Brady MS.
    Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes.
    Heyns CF, Theron PD.
    BJU Int; 2008 Aug; 102(3):305-9. PubMed ID: 18410439
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
    Frankel TL, Griffith KA, Lowe L, Wong SL, Bichakjian CK, Chang AE, Cimmino VM, Bradford CR, Rees RS, Johnson TM, Sabel MS.
    Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
    [Abstract] [Full Text] [Related]

  • 16. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
    Dalal KM, Patel A, Brady MS, Jaques DP, Coit DG.
    Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
    [Abstract] [Full Text] [Related]

  • 17. Investment in new technology research can save future health care dollars.
    Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse CW, Rapaport D, Berman C, Glass F, Fensske N, Einstein AB, Lyman G.
    J Fla Med Assoc; 1997 Mar; 84(3):175-81. PubMed ID: 9143169
    [Abstract] [Full Text] [Related]

  • 18. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM.
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
    Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, Künzi W, Giovanoli P.
    Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.